SCHEMBL6160870

SCHEMBL6160870

N#Cc1ccc(Oc2ccc(F)cc2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
KDM4E B2RXH2 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.54
ALDH1A1 P00352 2/20 0.54
OPRM1 P35372 1/20 0.52
HSPB1 P04792 1/20 0.51
PDE4B Q07343 1/20 0.49
MAP4K4 O95819 1/20 0.46
ALOX5AP P20292 3/20 0.44
FEN1 P39748 3/20 0.44
HTT P42858 1/20 0.44
HRH3 Q9Y5N1 2/20 0.41
CYP19A1 P11511 1/20 0.41
FPR2 P25090 1/20 0.41
SCN9A Q15858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
PRKAA2 P54646 1/20 0.40
HPGD P15428 1/20 0.40
P2RX3 P56373 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27368543 0.90 MEN1 (0.54) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL24665295 0.83 OPRM1 (0.52) L3MBTL1OPRM1PDE4BMAP4K4HTT
SCHEMBL8237112 0.83 KDM4E (0.54) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL6158872 0.83 OPRM1 (0.61) ALDH1A1OPRM1PDE4BMAP4K4ALOX5AP
SCHEMBL27299799 0.83 PDE4B (0.52) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL27299558 0.81 PDE4B (0.48) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL1222107 0.81 OPRM1 (0.50) MEN1KMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL3177956 0.80 OPRM1 (0.58) L3MBTL1OPRM1PDE4BMAP4K4FPR2
SCHEMBL6161241 0.80 OPRM1 (0.58) KDM4EL3MBTL1ALDH1A1OPRM1PDE4B
SCHEMBL1222067 0.80 ALDH1A1 (0.57) KDM4EL3MBTL1ALDH1A1OPRM1PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011078370-A1 NOVEL PARABANIC ACID DERIVATIVE AND DRUG HAVING THE SAME AS ACTIVE INGREDIENT 杏林製薬株式会社 (JP) 2011-06-30 WO disclosed
US-20050165064-A1 Novel thiol derivative, process for producing the same and use thereof TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. 2005-07-28 US disclosed
EP-1500658-A1 NOVEL THIOL DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050165064-A1 Novel thiol derivative, process for producing the same and use thereof TST, QSOX1, MMP1 MEN1 4321/4885KMT2A 2631/4885KDM4E 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.